| Brand Kigertropin, 10iu per vial, 10vials per kit. Description: Authentic kigtropin BRAND hgh, comes with boxes and labels. US domestic shipping avalible. 10iu/vial, 10vials/kit, Min order: 100 iu. Recombinant Human Growth Hormone for Injection NAME OF THE MEDICINAL PRODUCT Generic Name: Recombinant Human Growth Hormone Trade Name: KIGTROPIN INGREDIENTS Recombinant Human Growth Hormone and excipients. Molecular FormulaC990H1528N262O300S7 with 191 amino acids residues. Molecular Weight22125D Origin of the Active Ingredient: KIGTROPIN is a Recombinants Human Growth Hormone. KIGTROPIN is produced by recombinant DNA technology in E.coli secretion expression system. KIGTROPIN has the same amino acid sequence with 191 residues as the native human growth hormone produced in the human body. CHARACTERS White Lyophilized powder. INDICATION Growth failure of children due to endogenous growth hormone deficiency(GHD). In adults with growth hormone deficiency,KIGTROPIN reduces fat mass,increases muscle mass and improves energy,vitality and subjective well-being. In patients suffering from severe burns,AIDS associated muscle wasting,or undergoing major operations,KIGTROPIN promotes wound healing,attenuates the protein-catabolic response and improves whole-body nitrogen condition after operation. SPECIFICATIONS 10IU/3.7mg/1.0ml/vial DOSAGE AND ADMINISTRATION Before administration, add 1ml of sterile water for injection to the rhGH vial of Lyophilized powder along the wall slowly. Shake it gently to fully dissolve the powder to get clarified solution. DO NOT shake violently. For anti-aging, general health & healing, fat mobilization, a dose of 2-3 IU's per day will be sufficient for the majority. A dose of 1.5 to 2.0 IU's is considered to be a full replacement dose for those in their middle-age and beyond. For gaining lean muscle and substantially improving body composition, a dose of 4-8 IUs per day will be necessary. Most people will respond very well at a dose of 4-5 IU's per day. For maximum benefit in this regard, the addition of Testosterone, Insulin, and low-dose t3 would be something to seriously consider. More on this in our comparative cycle guide of HGH/Insulin/IGF. The recommended dosage for injection is 0.1-0.15IU/kg/day, inject before sleeping daily at the same time and the injection site should be changes frequently to prevent lipoatrophy at the site, or follow the physicians advice. ADVERSE REACTIONS Growth hormone may induce transient hyperglycosemia, which usually recover to normal level over time or after drug discontinuation. About 1% children with microsomia in the clinical trial presented side effects, which usually presented transient reactions at the injection site(pain, tingling numbness, red swelling, etc) and the symptoms of fluid retention(peripheral edema, arthralgia or myalgia). These side effects usually appear at early stage and the incidence rate decreases over time which rarely affects daily activities. Long-term injection of recombinant human growth hormone results in antibody production in minority people, however, the affinity of the antibody is low without exact clinical significance. The antibody may be induced if the anticipant effect of growth is not achieved, which may affect the efficacy if the affinity is over 2 mg/L. CONTRAINDICATIONS Children with closure of epiphysis are forbidden. Patients with the progressive symptoms of tumor are forbidden. Critical ill patients in acute shock stage of serious systematic infection are forbidden. WARNINGS AND PRECAUTIONS rhGH therapy should be conducted on exactly diagnosed GHD patients under advice of experienced doctor. For diabetes patients, dosage of anti-glucourea drugs should be adjusted during rhGH therapy. For patients whose GHD were caused by encephaloma or encephalic wound, the progress and relapse possibility of potential diseases should be closely monitored. For ACTH deficiency patients, dosage of ATCH should be adjusted because the growth improvement effect of rhGH could be inhibited by simultaneous |
